What happened to Gilead Sciences Inc (gild) stock?

Year-to-date, Gilead Sciences Inc (NASDAQ: GILD) stock gained 17.9% and on July 14th it had a closing price of $77.19. Here is what Silver Ring Value Partners said:

What does Gilead Sciences Inc (gild) do?

The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome,... View the latest Gilead Sciences Inc. (GILD) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Is Gilead Sciences a good stock to buy?

Gilead Sciences has received a consensus rating of Hold. The company's average rating score is 2.35, and is based on 6 buy ratings, 11 hold ratings, and no sell ratings. Gilead Sciences has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.